Please login to the form below

Not currently logged in
Email:
Password:

Still's disease

This page shows the latest Still's disease news and features for those working in and with pharma, biotech and healthcare.

FDA approves Biogen’s aducanumab for Alzheimer’s disease in ‘landmark’ decision

FDA approves Biogen’s aducanumab for Alzheimer’s disease in ‘landmark’ decision

the patient-centred outcome of clinical benefit, which has been required of all previous emerging treatments for Alzheimer’s disease,” the institute added. ... Still, patient representatives have counted the approval as a significant win for millions

Latest news

More from news
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Research Partnership

Research Partnership is now a member of Inizio Advisory, the consulting business unit of Inizio, a strategic partner for health...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....